Patents by Inventor Chun Wai Davy Lee

Chun Wai Davy Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-viral carbamimidothioic acid esters
    Patent number: 8742156
    Abstract: Carbamimidothioic acid esters of formula (I) and 2-nitro-N-[4-(pyridin-4-ylamino)phenyl]-4-(quinolin-4-ylamino)benzamide are used for the treatment of influenza, and for the inhibition of a viral RNA-dependent RNA polymerase. Formulae (I), (II).
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: June 3, 2014
    Assignees: British Columbia Cancer Agency Branch, Versitech Limited
    Inventors: Steven J. Jones, Allan Sik-Yin Lau, Jianghong An, Hing-Yee Law, Chun-Wai Davy Lee
  • Anti-influenza compounds
    Patent number: 8673884
    Abstract: The present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: March 18, 2014
    Assignees: Versitech Limited, British Columbia Cancer Agency Branch
    Inventors: Steven J. Jones, Allan Sik-Yin Lau, Jianghong An, Hing Yee Law, Chun Wai Davy Lee, Lit Man Poon
  • ANTI-VIRAL CARBAMIMIDOTHIOIC ACID ESTERS
    Publication number: 20130143961
    Abstract: Carbamimidothioic acid esters of formula (I) and 2-nitro-N-[4-(pyridin-4-ylamino)phenyl]-4-(quinolin-4-ylamino)benzamide are used for the treatment of influenza, and for the inhibition of a viral RNA-dependent RNA polymerase. Formulae (I), (II).
    Type: Application
    Filed: August 12, 2011
    Publication date: June 6, 2013
    Applicants: British Columbia Cancer Agency, Versitech Limited
    Inventors: Steven J. Jones, Allan Sik-Yin Lau, Jianghong An, Hing-Yee Law, Chun-Wai Davy Lee
  • ANTI-INFLUENZA COMPOUNDS
    Publication number: 20110009369
    Abstract: The present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus.
    Type: Application
    Filed: February 4, 2009
    Publication date: January 13, 2011
    Applicant: BRITISH COLUMBIA CANCER AGENCY BRANCH
    Inventors: Steven J. Jones, Allan Sik-Yin Lau, Jianghong An, Hing Yee Law, Chun Wai Davy Lee, Lit Man Poon